
Ferrer, Leti and Oryzon to collaborate in R&D
Catalan Economy
21 Nov 2009
Pharmaceutical companies Ferrer and Leti and biotech firm Oryzon have announced the creation of the Oncochip alliance to further develop cancer research in Catalonia. Madrid-based Ingenasa and Navarra’s CIMA are also to participate in the project.
With a budget of over EUR 20 million, Oncochip will focus on the design of therapies for early diagnosis of ovarian cancer, melanoma and colon cancer. Oryzon specializes in the detection of cancer biomarkers and is already working with Reig Jofré on uterine cancer research.
Ferrer, Leti and Oryzon also plan to create a new partnership next year to develop nanotechnology projects.
Source: Expansión Cataluña 16/11/2009
Related News and Success stories.
-
28 Jul 2025
Catalonia to launch Europe’s first 6G Low Earth Orbit satellite lab
-
21 Jul 2025
Barcelona's Exponential Day 2025: Vanessa Cann unveils the next AI revolution
-
18 Jul 2025
Catalonia moves up as a Strongly Innovative European Region and leads Spain
-
17 Jul 2025
Grifols invests €160 million in Barcelona and creates 400 jobs with a new plasma fractionation plant